baber/WOPTO huggingface dataset:
Patent NZ-594785-A (NZ)
Title: Methods for casein production
Inventor: UR-REHMAN SHAKEEL
IPC: A23C9/12
Filed: 2008-11-02
Abstract: Provided is a method of making a cheese product comprising the steps of: (a) preparing a mixture of a microfiltration retentate fraction and milkfat, wherein the microfiltration retentate is prepared by subjecting a starting product comprising skim milk having a pH of 6.5 to 6.8 to a microfiltration process, wherein the microfiltration process is carried out at a temperature of from 5 degree C to 15 degree C, and wherein the proportion of micellar casein to whey protein in the microfiltration retentate is 90:10; (b) forming a homogeneous cheese-milk from the mixture; (c) adding an acidulant to achieve a suitable acidity; (d) adding a starter culture; (e) adding rennet to cause formation of a coagulum; (f) cutting the coagulum; (g) heating and draining whey to produce cheese curd; and (h) forming the cheese curd into a cheese product.
Patent NZ-596166-A (NZ)
Title: Voltage pulse transformer using a triode electron tube having an anode, cathode and grid
Inventor: BIRNBACH CURTIS A
IPC: H01J3/02
Filed: 2007-05-30
Abstract: 596166 Disclosed is an electron-coupled transformer for generating a high voltage output pulse as an amplified version of an input pulse. The transformer is comprised of a cylindrical triode electron tube with a central anode (64) along the main axis of the tube and a grid (66) and cathode (68) radially spaced from the anode (64). The anode (64) has a first end connected to ground and a second end insulated with respect to ground. The cathode (68) forms a primary of the transformer and an ungrounded portion of the anode (64) forms a secondary of the transformer. The cathode (68) and the grid (66) form a travelling wave electron gun that produces a wave of ground potential in the transverse electric mode when the grid (66) is grounded with a pulse. The wave of ground potential propagates along the length of the travelling wave electron gun at the speed of light in a direction from the first end of the anode (64) to the second end of the anode (64). The wave of ground potential causes electrons stored in the cathode-grid gap to be extracted from the gap. The extracted electrons form a radially symmetric travelling front that sweeps along the anode (64) at the speed of light, causing a voltage output pulse on the second end of the anode (64), the magnitude of which is an amplified version of an input pulse applied to the cathode (68). The energy of the electron-coupled transformer is pumped in a linear fashion by at least the energy contained in distributed inter-electrode capacitance of the cathode (68) and grid (66).
Patent NZ-596444-A (NZ)
Title: Antiviral compounds
Inventor: COTTELL JEROMY J
IPC: C07D495/04
Filed: 2010-05-12
Abstract: 596444 Disclosed herein are anti-viral compounds, compositions containing such compounds, and the use of said compounds and compositions in the treatment of hepatitis C or a hepatitis C associated disorder, as well as to processes and intermediates useful for preparing such compounds. A preferred embodiment of the compound is (1-{ 3-[6-(9,9-difluoro-7-{ 2-[5-(2-methoxycarbonylamino-3-methylbutyryl)-5-aza-spiro[2.4]hept-6-yl]-3H-imidazol-4-yl} -9H-fluoren-2-yl)-1H-benzoimidazol-2-yl]-2-aza-bicyclo[2.2.1]heptane-2-carbonyl} -2-methyl-propyl)-carbamic acid methyl ester.
Patent NZ-597326-A (NZ)
Title: Matrix carrier compositions, methods and uses
Inventor: VOL ALEXANDER
IPC: A61K9/14
Filed: 2010-07-08
Abstract: Disclosed is a matrix carrier composition for use in pharmaceutical delivery system, the composition comprising an intermolecular association of at least: a first solid phase comprising nanoparticles having hydrophobic surface, wherein the size of the nanoparticles is in the range of about 5-1000 nm; a second solid phase, comprising a biopolymer having hydrophilic and hydrophobic parts; and a continuous phase comprising oil associated with said first and said second solid phases.
Patent NZ-599837-A (NZ)
Title: Method and apparatus for producing homogeneous magnetic fields
Inventor: PERNECKER SEBASTIEN
IPC: G01R33/32
Filed: 2010-12-01
Abstract: 599837 Disclosed is a method for shimming a magnetic field in which there is an inhomogeneity having more than one functional component. The magnetic field is produced by a magnet assembly (80) having two opposed and mutually distanced assembly ends. A plurality of commonly oriented shim paths (90) are provided such that the shim paths (90) are disposed on a common surface having two opposed and mutually distanced ends. Each of the surface ends has at least one associated electrical connector. A plurality of coordinately modulated single electronic shim currents are applied along corresponding ones of the plurality of shim paths (90), each of the electronic shim currents flowing from the electrical connector at one the surface end to the electrical connector at the other the surface end. The more than one functional components of the inhomogeneity in the magnetic field are suppressed using the plurality of electronic shim currents. Each of the surface ends is proximate a corresponding one of the assembly ends so that at least a portion of the shim currents flows from one the assembly (80) end towards the other the assembly end.
Patent NZ-600000-A (NZ)
Title: Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions
Inventor: GARRIGUE JEAN-SEBASTIEN
IPC: A61K9/00
Filed: 2010-11-19
Abstract: A composition for use in treating corneal and conjunctival lesions, includes a prostaglandin F2alpha or analogue, in a therapeutic amount, the composition being in a form suitable for topical application on the ocular surface and is free of deleterious preservative. A method for treating surface ocular conditions in a patient in need thereof, includes administering an effective amount of the composition.
Patent NZ-600360-A (NZ)
Title: Item display stand
Inventor: L’HOTEL FRANCOIS
IPC: A47F5/10
Filed: 2011-01-26
Abstract: A foldable item display stand (1) is disclosed. The stand (1) can be articulated between a folded state and an unfolded and open functional state ready to accept the item. At least one supporting wall (6) extends between two side walls (16, 17). Each side wall (16, 17) has at least one articulation edge (23, 24, 25, 26) along which the side wall can be folded and a further fold line (19) which intersects the at least one fold line. In the operational unfolded state, the edges (23, 24, 25, 26) form part of restraining and bracing means which along with the support wall (6) provide a vertical load supporting path for the item to be supported. A multi compartment display stand (1) can be folded both along its longitudinal extent by articulated edges (23, 24, 25, 26) and further folded along the additional fold lines (19) (see Figure 5) for transportation. The stand may be made from cardboard or other relatively rigid materials.
Patent NZ-600482-A (NZ)
Title: Microrna (miRNA)and downstream targets for diagnostic and therapeutic purposes
Inventor: THUM THOMAS
IPC: A61K31/7105
Filed: 2009-02-26
Abstract: 600482 Disclosed is an in vitro method for diagnosing fibrosis comprising measuring the expression of Sprouty1 protein in a sample from a patient supposed to suffer from fibrosis; wherein a reduced level of Sprouty1 in comparison to a control sample indicates fibrosis or a predisposition thereof. Further disclosed is an in vitro method for screening a pharmaceutically active compound for the treatment and/or prevention of fibrosis or a predisposition thereof, comprising the steps of: a. contacting the candidate substance with a sample containing Sprouty1; b. determining the effect of the candidate substance on the sample; wherein an alteration of Sprouty1 indicates a pharmaceutically active compound. Further disclosed is an in vitro method for increasing Sprouty1 protein in a fibroblast comprising contacting the fibroblast with a compound comprising a modified oligonucleotide consisting of 12 to 30 linked nucleosides, wherein the nuceobase sequence of the modified oligonucleotide is complementary to miR-21 or a precursor thereof, thereby stimulating Sprouty1 protein expression.
Patent NZ-600580-A (NZ)
Title: Biogasification of coal to methane and other useful products
Inventor: DOWNEY ROBERT A
IPC: C10L3/08
Filed: 2010-12-10
Abstract: 600580 Disclosed is a process for converting coal ex situ, comprising: (a) treating coal (such as lignite, sub-bituminous coal, bituminous coal, semi-anthracite coal, anthracite coal or a combination thereof) with a liquid (such as acetic acid, salts of acetic acid, or esters of acetic acid, nitrogenous ring aromatics (including acridine and carbazole), aromatic hydrocarbons (including phenanthrene, chrysene, fluoranthene, pyrene, anthracene and fluorene), catechol, creosote, heavy oils etc.) that solubilizes at least a portion of the coal, to form a product that is a substrate for a hydrolytic microbial population; (b) treating at least a portion of the product of step (a) with a hydrolytic microbial population to produce a product containing fatty acids; (c) treating at least a liquid portion of the product from step (b) with an anaerobic microbial population that generates methane to produce a product containing methane.
Patent NZ-603952-A (NZ)
Title: Phosphaplatins and their use for treatment of cancers
Inventor: BOSE RATHINDRA N
IPC: C07F15/00
Filed: 2011-06-02
Abstract: 603952 Disclosed are pyrodach platinum phosphaplatin complexes of formulae (I)-(VI). Further disclosed are the use of the complexes in the manufacture of a medicament for treating cancer and pharmaceutical compositions comprising complexes of formulae I-VI.
Patent NZ-609967-A (NZ)
Title: Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies
Inventor: GOTTSCHALK STEPHEN M G
IPC: A61K39/00
Filed: 2011-10-27
Abstract: Discloses use of a cell comprising a chimeric antigen receptor in the manufacture of a medicament for the treatment of a solid tumour cancer cell in an individual, wherein the chimeric antigen receptor recognises the CD70 antigen and comprises an intracellular signalling domain.
Patent NZ-613153-A (NZ)
Title: Fluid mixer and fluid mixing method
Inventor: HATA TAKASHI
IPC: B01F23/10
Filed: 2011-12-21
Abstract: 613153 In order to refine and also homogenize a dispersion phase on the micro-level to sub-micro-level inexpensively and with a simple structure, a cylindrical mixer body having openings at both ends is provided with: an axial flow path whereby a first fluid introduced from the opening at one end is made to flow in the axial direction and exit from the opening at the other end; and a helical flow path whereby a second fluid introduced from a body inlet formed in the peripheral wall of the mixer body is made to flow along the inner peripheral surface of the mixer body while swirling in a helical shape centered around the axis of the axial flow path so that the first fluid and second fluid are mixed and exit from the opening at the other end.
Patent NZ-613432-A (NZ)
Title: Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
Inventor: BODE LARS
IPC: A23L33/00
Filed: 2012-02-03
Abstract: Disclosed is an infant formula, baby food, or fortified breast milk, comprising a formulation comprising an isolated disialyllacto-N-tetraose (DSLNT) or isomer thereof and a probiotic, wherein the isolated DSLNT or isomer is free of non-DSLNT oligosaccharides and is present in the formulation at 300 μM or greater, wherein DSLNT is biologically active α-Neu5Ac-(2→3)-β-Gal-(1→3)-[α-Neu5Ac-(2→6)]-β-GlcNAc-(1→3)-β-Gal-(1→4)-Glc; and wherein the isomer is any of α-Neu5Ac-(2→3)- α-Gal-(1→3)-[α-Neu5Ac-(2→6)]-β-GlcNAc-(1→3)-β-Gal-(1→4)-Glc, α-Neu5Ac-(2→3)-β-Gal-(1→3)-[α-Neu5Ac-(2→6)]- α -GlcNAc-(1→3)-β-Gal-(1→4)-Glc, α-Neu5Ac-(2→3)-β-Gal-(1→3)-[α-Neu5Ac-(2→6)]-β-GlcNAc-(1→3)- α-Gal-(1→4)-Glc, β-Neu5Ac-(2→3)-β-Gal-(1→3)-[α-Neu5Ac-(2→6)]-β-GlcNAc-(1→3)-β-Gal-(1→4)-Glc, or α-Neu5Ac-(2→3)-β-Gal-(1→3)-[ β-Neu5Ac-(2→6)]-β-GlcNAc-(1→3)-β-Gal-(1→4)-Glc. Also disclosed is a formulation in the form of a tablet, caplet or powder comprising α-Neu5Ac-(2→3)- α-Gal-(1→3)-[α-Neu5Ac-(2→6)]-β-GlcNAc-(1→3)-β-Gal-(1→4)-Glc, α-Neu5Ac-(2→3)-β-Gal-(1→3)-[α-Neu5Ac-(2→6)]- α -GlcNAc-(1→3)-β-Gal-(1→4)-Glc, α-Neu5Ac-(2→3)-β-Gal-(1→3)-[α-Neu5Ac-(2→6)]-β-GlcNAc-(1→3)- α-Gal-(1→4)-Glc, β-Neu5Ac-(2→3)-β-Gal-(1→3)-[α-Neu5Ac-(2→6)]-β-GlcNAc-(1→3)-β-Gal-(1→4)-Glc, or α-Neu5Ac-(2→3)-β-Gal-(1→3)-[ β-Neu5Ac-(2→6)]-β-GlcNAc-(1→3)-β-Gal-(1→4)-Glc.
Patent NZ-617556-A (NZ)
Title: Screw cap
Inventor: MARTINENGO HERVÉ
IPC: B65D41/62
Filed: 2012-05-02
Abstract: A cap, top or lid (1) for sealing the top of a bottle (100) is described. The lid encloses or hermetically seals the mouth of the vessel until a frangible seal (15) is broken, operating as a screw-top thereafter. The lid comprises an outer cylindrical shell (11) with an upper fastening insert (20) with an internal helical thread (22) that engages with an external thread (311) on a second insert (31). The second insert (31) hooks or clamps onto a protrusion or relief of the bottle (101) so that the lid can be effectively screwed onto the bottle. Furthermore, the shell has a notch or indentation (12) that hooks onto the bottom of the second insert (322, 323), so that it cannot be unscrewed once it has been attached.
Patent NZ-626461-A (NZ)
Title: Cellulose mixed esters, process for preparation and uses
Inventor: GLENNY MARK
IPC: C09D101/14
Filed: 2012-12-05
Abstract: The disclosure relates to cellulose mixed esters of levulinic acid and an alkyl carboxylic acid such as acetic acid, propionic acid, butanoic acid, isobutanoic acid, pentanoic acid or hexanoic acid, processes for preparing these and uses of the cellulose mixed esters, for example in coating compositions. These cellulose mixed esters have glass transition temperatures that fall within an appropriate range to allow for film formation to occur at ambient temperatures and have a total degree of substitution per anhydroglucose unit of about 2.5 to about 3.5; a residual hydroxyl functionality per anhydroglucose unit of 0 to about 0.5; a degree of substitution per anhydroglucose unit by C2-C6 ester groups of about 0.5 to about 2.8; and a degree of substitution per anhydroglucose unit by levulinyl ester groups of about 0.2 to about 2.6.
Patent NZ-631082-A (NZ)
Title: Methods for treating cancer using tor kinase inhibitor combination therapy
Inventor: RAYMON HEATHER
IPC: A61P35/02
Filed: 2014-04-16
Abstract: Disclosed herein is the use of an effective amount of an effective amount of a TOR kinase inhibitor represented by structural formula (I) and an effective amount of a cytidine analog in the manufacture of a medicament for treating or preventing cancer, particularly blood borne cancer which includes a lymphoma, a leukemia or a mutliple myeloma, wherein the variables shown in formula (I) are as defined in the specification.
Patent NZ-710927-A (NZ)
Title: Peroxycarboxylic acid compositions containing mineral acids for stabilization, anionic surfactants for defoaming, and fluorescent active compounds for inline optical or conductivity monitoring
Inventor: LI JUNZHONG
IPC: A61L2/16
Filed: 2014-02-20
Abstract: Highly acidic, stabilized and low foaming peroxycarboxylic acid compositions are disclosed as having both improved antimicrobial efficacy in comparison to conventional peroxyoctanoic acid and peroxyacetic acid compositions for sanitizing applications, and improved transport and shipping stability. Peroxycarboxylic acid sanitizing compositions containing a peroxycarboxylic acid stabilizing agent, such as picolinic acid or a compound having the Formula (IA), or a salt thereof; or a compound having the Formula (IB), or a salt thereof; are disclosed. Beneficially, the sanitizing peroxycarboxylic acid compositions are also low odor and low/no VOC dual functioning acid wash and sanitizing compositions.
Patent NZ-711713-A (NZ)
Title: Directional differential pressure detector
Inventor: WISEMAN BRIAN
IPC: G08B21/00
Filed: 2014-03-12
Abstract: Various applications within hospitals, laboratories, pharmaceutical facilities, clean room facilities, etc., often require a particular direction of air flow to be maintained, such as between neighbouring rooms, compartments, corridors, ducts, or other spaces. The pressure of a room relative to adjacent space(s) will determine the net direction of air flow through an opening into or out of the room. There is needed a simple device which can be used to indicate the presence of a range of desired pressure differentials. According to the present invention, methods and apparatuses for indicating the presence of a directional differential pressure between separated adjacent spaces are provided. A gravity-based differential pressure set point indicator (200a) may be configured to correlate multiple potential angles of inclination of an elongated conduit (110) to respective threshold differential pressures between two spaces (10, 20) which are sufficient to cause a lightweight ball (120) to move from one region of the conduit to an opposing region.
Patent NZ-720395-A (NZ)
Title: Mixer drum apparatus
Inventor: SAKAI NAOTO
IPC: B60P3/16
Filed: 2012-08-08
Abstract: A concrete mixing drum or barrel is disclosed. The drum (9) has spiral or helical blades (20, 30) inside, and includes an inlet seal (40) at the opening of the drum. The inlet seal has triangular side panels (42) the contour to the side of the blade and define an opening (28) through the middle of the drum. Each of the inlet seal panels has a seal side portion, that defines the opening, wherein the seal side portion extends in a linear manner along a reference line extending in parallel to the rotation centre axis of the drum and has an extended portion formed along a corresponding one of the blades
Patent NZ-728557-A (NZ)
Title: Use of materials incorporating microparticles for avoiding the proliferation of contaminants
Inventor: MARCHIN LOÏC
IPC: A61L2/238
Filed: 2015-06-25
Abstract: The present application relates to use of a solid material comprising a matrix and dispersed zinc oxide (ZnO) and/or magnesium oxide (MgO) microparticles for preventing, limiting and/or eliminating the contamination of said material and/or the contamination of a composition which is in contact with said material for at least a given time, and/or preventing, eliminating and/or slowing down the formation of biofilms on the surface of said material, wherein the ZnO and/or MgO does not migrate out of said material. The application also relates to the use of such material for manufacturing an article, to the process for manufacturing said article, and to the article obtained. In particular, the article is selected from stoppers, lids, seals, caps, covers, plugs and valves intended for sealing bottles, flasks, jars, cans, canisters, barrels, tanks, or various containers used for packaging and/or storing food products, dietetic products, cosmetic products, dermatological products or pharmaceutical products.
Patent NZ-740521-A (NZ)
Title: Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same
Inventor: BUNTING STUART
IPC: A61K39/12
Filed: 2016-09-23
Abstract: The invention provides adeno-associated virus (AAV) Factor VIII (FVIII)- encoding/expressing vectors and virus, including AAV FVIII vectors with high expression activity and AAV FVIII vectors that express full-length or truncated functional FVIII protein. The invention also relates to methods of making the herein described AAV FVIII vectors, recombinant AAV FVIII virus particles comprising or expressing such vectors, associated pharmaceutical formulations comprising the same and therapeutic uses thereof.
Patent NZ-743729-A (NZ)
Title: Technique for directing audio in augmented reality system
Inventor: MILLER SAMUEL A
IPC: G02B27/18
Filed: 2017-02-02
Abstract: A hearing aid and virtual image generation system including said hearing aid and a display subsystem, the system being useful in augmented reality environments. The hearing aid comprises a sensor to detect a focus of an end user on a real sound source, an adaptive microphone assembly, a speaker, and a control subsystem configured for modifying, based on the detected focus of the user, a direction of a greatest sensitivity of the adaptive microphone assembly, and a distance of the greatest sensitivity, wherein the control subsystem is configured to compare characteristics of a first sound from the real source to characteristics of a second sound from a different source, emphasizing sounds having the same type of characteristics as the characteristics of the first sounds, and deemphasizing sounds having the same characteristics as the second sound. The display subsystem displays three-dimensional images, generated by the control subsystem, to the end user.
Patent NZ-751261-A (NZ)
Title: Bicyclic nitrogenated heterocyclic compound
Inventor: NAKAJIMA TATSUO
IPC: A61P11/02
Filed: 2017-08-25
Abstract: The present invention provides: a novel use of a specific bicyclic nitrogenated heterocyclic compound as a PDE7 inhibitor; a novel bicyclic nitrogenated heterocyclic compound having a PDE7 inhibition activity, a method for producing the compound, a use of the compound, and a pharmaceutical composition containing the PDE7 inhibitor or the compound; and others. More specifically, the present invention provides a PDE7 inhibitor containing, as an active ingredient, a compound represented by formula (I) [wherein the symbols have the same meanings as those described in the description] or a pharmacologically acceptable salt thereof.
Patent NZ-768214-A (NZ)
Title: Visualization interfaces for real-time identification, tracking, and prediction of space objects
Inventor: HENDRIX DOUGLAS
IPC: G06T11/20
Filed: 2019-02-21
Abstract: A system for displaying measurements of objects in orbit can include a display interface that includes a longitude-time graph. The interface can include a longitude axis spanning from a lower-longitude limit to an upper-longitude limit, a time axis spanning from a lower-time limit to an upper-time limit, and a plurality of pixels corresponding to longitude-time points within the longitude-time graph. Each of the plurality of longitude-time points may correspond to a data set that includes the historical data and the contemporary data. The data set includes a time identifier between the lower-time limit and the upper-time limit and a longitude identifier between the lower-longitude limit and the upper-longitude limit.
Patent PT-100943-A (PT)
Inventor: MILLAR ALAN
IPC: C07C255/21
Filed: 1992-10-09
Abstract: An improved process for the preparation of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate is described where a halo hydroxyester or other activated dihydroxyester is converted in two steps to the desired product.
Patent PT-104129-A (PT)
Title: Método de análise comportamental com base num módulo tridimensional de vivências e sua aplicação
Inventor: MACHADO HELDER DA COSTA
IPC: G16H10/60
Filed: 2008-07-10
Abstract: A PRESENTE INVENÇÃO RELACIONA-SE COM A IDENTIFICAÇÃO, UTILIZAÇÃO E AVALIAÇÃO DE TRÊS FACTORES DE ORDEM PSICOSSOCIAL E ESTILOS DE VIDA MAIS PREVALENTES, ACONTECIMENTOS VITAIS E DISPOSIÇÕES DOS DOENTES E O SEU IMPACTO NA DOENÇA. PARA PERMITIR A MATERIALIZAÇÃO DAS COMPONENTES DE ANÁLISE, RECORRE-SE À SUA AVALIAÇÃO, QUANTIFICAÇÃO E REPRESENTAÇÃO ICONOGRÁFICA ATRAVÉS DE UM REGISTO ELECTRÓNICO DE SAÚDE ASSENTE NUMA ESTRUTURA TRIDIMENSIONAL EM FORMA DE ''RETRATO'' DE CADA UTENTE, COMPOSTO POR ''PEÇAS ICONOGRÁFICAS'', VARIÁVEIS, QUE DERIVAM DAQUELES TRÊS FACTORES E TRADUZEM PROBLEMAS A RESOLVER. O PRESENTE MÉTODO QUANTIFICA O RISCO E REVELA PADRÕES DO ESTADO DE SAÚDE DE CADA UTENTE, CONSTITUINDO UM INSTRUMENTO DE APOIO À AVALIAÇÃO DOS FACTORES PSICOSSOCIAIS DE PESO NA SAÚDE DAS POPULAÇÕES, COM APLICAÇÃO NO SECTOR DAS CIÊNCIAS DA SAÚDE, AO APONTAR NO SENTIDO DE ACÇÕES PREVENTIVAS E TERAPÊUTICAS A CARGO DOS PROFISSIONAIS E NO SECTOR DA SEGURANÇA SOCIAL ONDE POSSIBILITA A INVENTARIAÇÃO DOS PROBLEMAS DOS UTENTES.